TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 19 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $17,178,000 | -60.0% | 978,200 | -77.9% | 0.00% | -66.7% |
| Q2 2021 | $42,985,000 | +2.5% | 4,431,459 | +13.5% | 0.01% | -10.0% |
| Q1 2021 | $41,929,000 | -37.7% | 3,903,951 | -14.7% | 0.01% | -44.4% |
| Q4 2020 | $67,287,000 | +18.5% | 4,574,222 | +14.5% | 0.02% | +12.5% |
| Q3 2020 | $56,775,000 | +99.8% | 3,995,512 | +13.7% | 0.02% | +60.0% |
| Q2 2020 | $28,420,000 | +97.7% | 3,512,864 | -1.3% | 0.01% | +66.7% |
| Q1 2020 | $14,372,000 | +130554.5% | 3,557,334 | +10093.2% | 0.01% | – |
| Q3 2019 | $11,000 | -72.5% | 34,899 | +50.2% | 0.00% | – |
| Q4 2018 | $40,000 | -77.8% | 23,229 | -5.7% | 0.00% | – |
| Q4 2017 | $180,000 | – | 24,622 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |